(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraen-1-ol; [(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenyl] acetate; [(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenyl] hexadecanoate
(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraen-1-ol; [(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenyl] acetate; [(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6
Listed by the Saudi Food and Drug Authority as restricted in cosmetic products; open the cited detail for the current conditions.
Regulatorische Entscheidung und vollständige Bedingungen
- Status
- Restricted
- Rechtsrolle
- Binding rule
- Regulatorische Zusammenfassung
- Listed by the Saudi Food and Drug Authority as restricted in cosmetic products; open the cited detail for the current conditions.
- Bedingungen und Beschränkungen
- If this row does not reproduce conditions, open the cited official detail because omission does not mean unrestricted use. Öffnen Sie die zitierte Quelle und wenden Sie die unten genannten marktweiten Anforderungen an.
Stoffidentität
- Name in der amtlichen Quelle
- (2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraen-1-ol; [(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenyl] acetate; [(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenyl] hexadecanoate
- CAS
- 11103-57-4; 68-26-8; 127-47-9; 79-81-2
- EC
- 204-844-2
- Identitätszuordnung
- cas_number
- Verknüpfter Inhaltsstoff
- RETINYL ACETATE
Verknüpfte CosIng-Identitätsdaten
Namen und Aliase
CosIng-Beschreibung: Retinyl acetate
Erfasste kosmetische Funktion: SKIN CONDITIONING, SKIN CONDITIONING - MISCELLANEOUS
Funktionsseiten:SKIN CONDITIONING, SKIN CONDITIONING - MISCELLANEOUS
Das vollständige Inhaltsstoffprofil ansehenMarktübergreifende Übersicht zu dieser Identität
Exakte verknüpfte Einträge, die derzeit auf dieser Website vorhanden sind. Ein fehlender Markt bedeutet, dass kein exakter Treffer importiert wurde, nicht dass der Stoff verwendet werden darf.
European Union
1 verknüpfter Eintrag · 1 mit besonderen Bedingungen
Unterstützenden Eintrag öffnenCanada
1 verknüpfter Eintrag · 1 mit besonderen Bedingungen
Unterstützenden Eintrag öffnenSaudi Arabia
Aktueller Eintrag1 verknüpfter Eintrag
Unterstützenden Eintrag öffnen
Verifizierte Chemie für CAS 11103-57-4
Retinol
All-trans-retinol is a retinol in which all four exocyclic double bonds have E- (trans-) geometry. It has a role as a mouse metabolite, a plant metabolite and a human metabolite. It is a vitamin A and a retinol. — ChEBI
- IUPAC-Name
- (2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraen-1-ol
- Summenformel
- C20H30O
- Molekulargewicht
- 286.5 g/mol
- Exakte Masse
- 286.229665576 Da
- Monoisotopische Masse
- 286.229665576 Da
- XLogP3
- 5,7
- Topologische polare Oberfläche
- 20,2 Ų
- Molekulare Komplexität
- 496,0
- Formale Ladung
- 0
- Wasserstoffbrücken-Donoren
- 1
- Wasserstoffbrücken-Akzeptoren
- 1
- Drehbare Bindungen
- 5
- Schweratome
- 21
- Kovalente Einheiten
- 1
An PubChem gemeldete Namen und Synonyme
16 weitere gemeldete Namen
Kennungen in externen Datenbanken
Erweiterte Strukturstatistik
- Definierte Atom-Stereozentren
- 0
- Nicht definierte Atom-Stereozentren
- 0
- Definierte Bindungs-Stereozentren
- 4
- Nicht definierte Bindungs-Stereozentren
- 0
- 3D-Pharmakophormerkmale
- 6
- 3D-Ringe
- 1
- 3D-Hydrophobe
- 3
- 3D-Akzeptormerkmale
- 1
- 3D-Donormerkmale
- 1
- 3D-Anionenzentren
- 0
- 3D-Kationenzentren
- 0
- 3D-Konformere
- 10
- Effektive 3D-Rotoren
- 5,8
Maschinenlesbare Strukturkennungen
- SMILES
CC1=C(C(CCC1)(C)C)/C=C/C(=C/C=C/C(=C/CO)/C)/C- InChI
InChI=1S/C20H30O/c1-16(8-6-9-17(2)13-15-21)11-12-19-18(3)10-7-14-20(19,4)5/h6,8-9,11-13,21H,7,10,14-15H2,1-5H3/b9-6+,12-11+,16-8+,17-13+- InChIKey
FPIPGXGPPPQFEQ-OVSJKPMPSA-N
Belege aus weiteren wissenschaftlichen Datenbanken
NIH PubChem PUG-View
Attributed physical-property, hazard, environmental and use annotations.
- Boiling Point: 279 to 280 °F at 1e-06 mmHg (NTP, 1992) Quelle: CAMEO Chemicals
- Boiling Point: 137-138 °C at 1X10-6 mm Hg Quelle: Hazardous Substances Data Bank (HSDB)
- Color/Form: Solvated crystals from polar solvents, such as methanol or ethyl formate Quelle: Hazardous Substances Data Bank (HSDB)
- LogP: 5.68 Quelle: DrugBank
- LogP: log Kow = 5.68 Quelle: Hazardous Substances Data Bank (HSDB)
- LogP: 5.68 Quelle: Human Metabolome Database (HMDB)
- Melting Point: 144 to 147 °F (NTP, 1992) Quelle: CAMEO Chemicals
- Melting Point: 63.5 °C Quelle: DrugBank
- Melting Point: 62-64 °C Quelle: Hazardous Substances Data Bank (HSDB)
- Melting Point: Pale yellow prismatic crystals from methanol; mp: 57-58 °C; UV max (ethanol): 326 nm (E=1,550, 1%, 1 cm) /Retinol acetate/ Quelle: Hazardous Substances Data Bank (HSDB)
- Melting Point: Amorphous or crystalline; mp: 28-29 °C; UV max (ethanol); 325-328 nm (E=975, 1%, 1 cm) /Retinol palmitate/ Quelle: Hazardous Substances Data Bank (HSDB)
- Melting Point: 61 - 63 °C Quelle: Human Metabolome Database (HMDB)
- Physical Description: Vitamin a appears as yellow crystals or orange solid. Practically water insoluble. (NTP, 1992) Quelle: CAMEO Chemicals
- Physical Description: Solid; [Merck Index] Yellow or orange solid; [NTP] Quelle: Haz-Map, Information on Hazardous Chemicals and Occupational Diseases
- Physical Description: Solid Quelle: Human Metabolome Database (HMDB)
- Refractive Index: Index of refraction: 1.6410 at 20 °C/D (calculated form refractive indexes of 20-70% solutions in mineral oil); max absorption: 324-325 nm (E=1,835, 1%, 1 cm) Quelle: Hazardous Substances Data Bank (HSDB)
- Solubility: Practically insoluble (NTP, 1992) Quelle: CAMEO Chemicals
- Solubility: 0.671 mg/L Quelle: DrugBank
- Solubility: Practically insoluble in water or glycerol; soluble in absolute alcohol, methanol, chloroform, ether, fats and oils Quelle: Hazardous Substances Data Bank (HSDB)
- Solubility: Sol in ethanol and acetone and benzene Quelle: Hazardous Substances Data Bank (HSDB)
- Vapor Pressure: 0.00000008 [mmHg] Quelle: Haz-Map, Information on Hazardous Chemicals and Occupational Diseases
- Vapor Pressure: 7.5X10-8 mm Hg at 25 °C /Estimated/ Quelle: Hazardous Substances Data Bank (HSDB)
- Carcinogen Classification: No indication of carcinogenicity to humans (not listed by IARC). Quelle: Toxin and Toxin Target Database (T3DB)
- Exposure Routes: Oral, readily absorbed from the normal gastrointestinal tract Quelle: Toxin and Toxin Target Database (T3DB)
- First Aid: EYES: First check the victim for contact lenses and remove if present. Flush victim's eyes with water or normal saline solution for 20 to 30 minutes while simultaneously calling a hospital or poison control center. Do not put any ointments, oils, or medication in the victim's eyes without specific instructions from a physician. If symptoms (such as redness or irritation) develop, immediately transport the victim to a hospital.; SKIN: IMMEDIATELY flood affected skin with water while removing and isolating all contaminated clothing. Gently wash all affected skin areas thoroughly with soap and water. If symptoms such as redness or irritation develop, IMMEDIATELY call a physician and be prepared to transport the victim to a hospital for treatment.; INHALATION: IMMEDIATELY leave the contaminated area; take deep breaths of fresh air. If symptoms (such as wheezing, coughing, shortness of breath, or burning in the mouth, throat, or chest) develop, call a physician and be prepared to transport the victim to a hospital. Provide proper respiratory protection to rescuers entering an unknown atmosphere. Whenever possible, Self-Contained Breathing Apparatus (SCBA) should be used; if not availabl Quelle: CAMEO Chemicals
- Note: This chemical does not meet GHS hazard criteria for 0.3% (1 of 311) of reports. Quelle: European Chemicals Agency (ECHA)
- Signal: Danger Quelle: European Chemicals Agency (ECHA)
- GHS Hazard Statements: H302 (15.8%): Harmful if swallowed [Warning Acute toxicity, oral]; H317 (74.9%): May cause an allergic skin reaction [Warning Sensitization, Skin]; H319 (75.6%): Causes serious eye irritation [Warning Serious eye damage/eye irritation]; H360 (88.1%): May damage fertility or the unborn child [Danger Reproductive toxicity]; H413 (74.9%): May cause long lasting harmful effects to aquatic life [Hazardous to the aquatic environment, long-term hazard] Quelle: European Chemicals Agency (ECHA)
- Precautionary Statement Codes: P203, P261, P264, P264+P265, P270, P272, P273, P280, P301+P317, P302+P352, P305+P351+P338, P318, P321, P330, P333+P317, P337+P317, P362+P364, P405, and P501 (click each P-code to see the statement) Quelle: European Chemicals Agency (ECHA)
- ECHA C&L Notifications Summary: Aggregated GHS information provided per 311 reports by companies from 14 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.; Reported as not meeting GHS hazard criteria per 1 of 311 reports by companies.; There are 13 notifications provided by 310 of 311 reports by companies with hazard statement code(s).; Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. For more detailed information, please visit ECHA C&L website. Quelle: European Chemicals Agency (ECHA)
- Note: This chemical does not meet GHS hazard criteria for 1% (1 of 105) of reports. Quelle: European Chemicals Agency (ECHA)
- GHS Hazard Statements: H317 (99%): May cause an allergic skin reaction [Warning Sensitization, Skin]; H319 (99%): Causes serious eye irritation [Warning Serious eye damage/eye irritation]; H360D (99%): May damage the unborn child [Danger Reproductive toxicity] Quelle: European Chemicals Agency (ECHA)
- Precautionary Statement Codes: P203, P261, P264+P265, P272, P280, P302+P352, P305+P351+P338, P318, P321, P333+P317, P337+P317, P362+P364, P405, and P501 (click each P-code to see the statement) Quelle: European Chemicals Agency (ECHA)
- ECHA C&L Notifications Summary: Aggregated GHS information provided per 105 reports by companies from 2 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.; Reported as not meeting GHS hazard criteria per 1 of 105 reports by companies.; There is 1 notification provided by 104 of 105 reports by companies with hazard statement code(s).; Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. For more detailed information, please visit ECHA C&L website. Quelle: European Chemicals Agency (ECHA)
- Cosmetic Ingredient Review Finding(s): Safe in the present practices of use and concentration. Ingredient, concentration, and use information are available in documents discoverable at https://cir-reports.cir-safety.org Quelle: Cosmetic Ingredient Review (CIR)
- Toxicity Summary: Signs and Symptoms of Overdose; Vitamin A toxicity may present with various clinical symptoms, including abdominal pain, headache, nausea, and facial flushing. Laboratory findings often include mild anemia, thrombocytopenia, elevated liver function tests, and a significant increase in serum retinol levels. Although the diagnosis is primarily clinical, laboratory tests such as serum retinol or retinyl ester levels can assist in confirming the diagnosis. A thorough dietary history is essential to identify excessive vitamin A intake.; Management of Overdose; Symptoms of toxicity may resolve within several weeks after discontinuing vitamin A and initiating supportive therapy. Patients with increased intracranial pressure may require lumbar punctures or medications such as mannitol and diuretics for management. Patients with hypercalcemia may need intravenous fluids and additional treatments, such as calcitonin and corticosteroids. Vitamin A toxicity can present with a range of clinical features, including abdominal pain, headache, nausea, and facial flushing. Laboratory findings often show mild anemia, thrombocytopenia, elevated liver function tests, and a significant increase in serum Quelle: StatPearls
- Toxicity Summary: Vision:Vitamin A (all-trans retinol) is converted in the retina to the 11-cis-isomer of retinaldehyde or 11-cis-retinal. 11-cis-retinal functions in the retina in the transduction of light into the neural signals necessary for vision. 11-cis-retinal, while attached to opsin in rhodopsin is isomerized to all-trans-retinal by light. This is the event that triggers the nerve impulse to the brain which allows for the perception of light. All-trans-retinal is then released from opsin and reduced to all-trans-retinol. All-trans-retinol is isomerized to 11-cis-retinol in the dark, and then oxidized to 11-cis-retinal. 11-cis-retinal recombines with opsin to re-form rhodopsin. Night blindness or defective vision at low illumination results from a failure to re-synthesize 11-cis retinal rapidly. Epithelial differentiation: The role of Vitamin A in epithelial differentiation, as well as in other physiological processes, involves the binding of Vitamin A to two families of nuclear retinoid receptors (retinoic acid receptors, RARs; and retinoid-X receptors, RXRs). These receptors function as ligand-activated transcription factors that modulate gene transcription. When there is not enough Vitami Quelle: Toxin and Toxin Target Database (T3DB)
- Cosmetic Ingredient Review Link: CIR ingredient: Retinol Quelle: Cosmetic Ingredient Review (CIR)
- Sources/Uses: Essential micronutrient found in animals; [Merck Index] Used as a nutritional supplement for foods; [FDA] Permitted for use as an inert ingredient in non-food pesticide products; [EPA] Quelle: Haz-Map, Information on Hazardous Chemicals and Occupational Diseases
- Uses: Vitamin (antixerophthalmic) Quelle: Hazardous Substances Data Bank (HSDB)
- Uses: MEDICATION Quelle: Hazardous Substances Data Bank (HSDB)
- Uses: MEDICATION (VET) Quelle: Hazardous Substances Data Bank (HSDB)
- Uses: For the treatment of vitamin A deficiency. Vitamin A helps regulate the immune system, which helps prevent or fight off infections by making white blood cells that destroy harmful bacteria and viruses. Quelle: Toxin and Toxin Target Database (T3DB)
Zugeordnet durch: Existing checksum-valid CAS to unique PubChem CID match. Abgerufen: 2026-08-31. Quelleneintrag öffnen
Wissenschaftliche Klassifizierungen und Gefahrenannotationen liefern Kontext und ersetzen nicht die oben gezeigte marktspezifische regulatorische Entscheidung.
Weitere Quellenabdeckung und Trefferstatus
| Quelle | Ergebnis | Geprüft |
|---|---|---|
| NIH PubChem PUG-View | Exakter Treffer | 2026-08-31 |
Ein erfasster Nicht-Treffer ist ein nützlicher Beleg dafür, dass die Quelle geprüft wurde; er ist keine Behauptung, dass der Stoff anderswo nicht existiert.
Am 2026-08-31 von NIH PubChem durch prüfsummengültigen CAS-Abgleich abgerufen. Chemische Eigenschaften ersetzen nicht die regulatorische Entscheidung auf dieser Seite.

Verifizierte Chemie für CAS 127-47-9
Retinol, acetate
Retinyl acetate is an acetate ester. It is functionally related to an all-trans-retinol. — ChEBI
- IUPAC-Name
- [(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenyl] acetate
- Summenformel
- C22H32O2
- Molekulargewicht
- 328.5 g/mol
- Exakte Masse
- 328.240230259 Da
- Monoisotopische Masse
- 328.240230259 Da
- XLogP3
- 6,3
- Topologische polare Oberfläche
- 26,3 Ų
- Molekulare Komplexität
- 595,0
- Formale Ladung
- 0
- Wasserstoffbrücken-Donoren
- 0
- Wasserstoffbrücken-Akzeptoren
- 2
- Drehbare Bindungen
- 7
- Schweratome
- 24
- Kovalente Einheiten
- 1
An PubChem gemeldete Namen und Synonyme
16 weitere gemeldete Namen
Kennungen in externen Datenbanken
- ChEBI:CHEBI:32095
- ChEBI:CHEBI:94695
- ChEMBL:CHEMBL486193
- EPA DTXSID:DTXSID6021240
- PubMed:228596
Erweiterte Strukturstatistik
- Definierte Atom-Stereozentren
- 0
- Nicht definierte Atom-Stereozentren
- 0
- Definierte Bindungs-Stereozentren
- 4
- Nicht definierte Bindungs-Stereozentren
- 0
- 3D-Pharmakophormerkmale
- 5
- 3D-Ringe
- 1
- 3D-Hydrophobe
- 3
- 3D-Akzeptormerkmale
- 1
- 3D-Donormerkmale
- 0
- 3D-Anionenzentren
- 0
- 3D-Kationenzentren
- 0
- 3D-Konformere
- 10
- Effektive 3D-Rotoren
- 7,8
Maschinenlesbare Strukturkennungen
- SMILES
CC1=C(C(CCC1)(C)C)/C=C/C(=C/C=C/C(=C/COC(=O)C)/C)/C- InChI
InChI=1S/C22H32O2/c1-17(9-7-10-18(2)14-16-24-20(4)23)12-13-21-19(3)11-8-15-22(21,5)6/h7,9-10,12-14H,8,11,15-16H2,1-6H3/b10-7+,13-12+,17-9+,18-14+- InChIKey
QGNJRVVDBSJHIZ-QHLGVNSISA-N
Belege aus weiteren wissenschaftlichen Datenbanken
NIH PubChem PUG-View
Attributed physical-property, hazard, environmental and use annotations.
- Carcinogen Classification: No indication of carcinogenicity to humans (not listed by IARC). Quelle: Toxin and Toxin Target Database (T3DB)
- Note: This chemical does not meet GHS hazard criteria for 0.3% (1 of 374) of reports. Quelle: European Chemicals Agency (ECHA)
- Signal: Danger Quelle: European Chemicals Agency (ECHA)
- GHS Hazard Statements: H315 (83.4%): Causes skin irritation [Warning Skin corrosion/irritation]; H360 (59.4%): May damage fertility or the unborn child [Danger Reproductive toxicity]; H361 (39.6%): Suspected of damaging fertility or the unborn child [Warning Reproductive toxicity]; H413 (64.4%): May cause long lasting harmful effects to aquatic life [Hazardous to the aquatic environment, long-term hazard] Quelle: European Chemicals Agency (ECHA)
- Precautionary Statement Codes: P203, P264, P273, P280, P302+P352, P318, P321, P332+P317, P362+P364, P405, and P501 (click each P-code to see the statement) Quelle: European Chemicals Agency (ECHA)
- ECHA C&L Notifications Summary: Aggregated GHS information provided per 374 reports by companies from 22 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.; Reported as not meeting GHS hazard criteria per 1 of 374 reports by companies.; There are 21 notifications provided by 373 of 374 reports by companies with hazard statement code(s).; Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. For more detailed information, please visit ECHA C&L website. Quelle: European Chemicals Agency (ECHA)
Zugeordnet durch: Existing checksum-valid CAS to unique PubChem CID match. Abgerufen: 2026-08-31. Quelleneintrag öffnen
Wissenschaftliche Klassifizierungen und Gefahrenannotationen liefern Kontext und ersetzen nicht die oben gezeigte marktspezifische regulatorische Entscheidung.
Weitere Quellenabdeckung und Trefferstatus
| Quelle | Ergebnis | Geprüft |
|---|---|---|
| NIH PubChem PUG-View | Exakter Treffer | 2026-08-31 |
Ein erfasster Nicht-Treffer ist ein nützlicher Beleg dafür, dass die Quelle geprüft wurde; er ist keine Behauptung, dass der Stoff anderswo nicht existiert.
Am 2026-08-31 von NIH PubChem durch prüfsummengültigen CAS-Abgleich abgerufen. Chemische Eigenschaften ersetzen nicht die regulatorische Entscheidung auf dieser Seite.

Verifizierte Chemie für CAS 79-81-2
Retinol Palmitate
All-trans-retinyl palmitate is an all-trans-retinyl ester obtained by formal condensation of the carboxy group of palmitic (hexadecanoic acid) with the hydroxy group of all-trans-retinol. It is used in cosmetic products to treat various skin disorders such as acne, skin aging, wrinkles, dark spots, and also protect against psoriasis. It has a role as an antioxidant, a human xenobiotic metabolite and an Escherichia coli metabolite. It is a retinyl palmitate and an all-trans-retinyl ester. It is functionally related to an all-trans-retinol. — ChEBI
- IUPAC-Name
- [(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenyl] hexadecanoate
- Summenformel
- C36H60O2
- Molekulargewicht
- 524.9 g/mol
- Exakte Masse
- 524.45933115 Da
- Monoisotopische Masse
- 524.45933115 Da
- XLogP3
- 13,6
- Topologische polare Oberfläche
- 26,3 Ų
- Molekulare Komplexität
- 803,0
- Formale Ladung
- 0
- Wasserstoffbrücken-Donoren
- 0
- Wasserstoffbrücken-Akzeptoren
- 2
- Drehbare Bindungen
- 21
- Schweratome
- 38
- Kovalente Einheiten
- 1
An PubChem gemeldete Namen und Synonyme
16 weitere gemeldete Namen
Kennungen in externen Datenbanken
- ChEBI:CHEBI:17616
- ChEMBL:CHEMBL1675
- EPA DTXSID:DTXSID1021241
- PubMed:38191030
- PubMed:32846153
- PubMed:20679000
- PubMed:19686701
- PubMed:17377406
- PubMed:17303254
- PubMed:17299104
- PubMed:17164434
- PubMed:16798117
- PubMed:16741517
- PubMed:16497549
- PubMed:16299098
Erweiterte Strukturstatistik
- Definierte Atom-Stereozentren
- 0
- Nicht definierte Atom-Stereozentren
- 0
- Definierte Bindungs-Stereozentren
- 4
- Nicht definierte Bindungs-Stereozentren
- 0
- 3D-Konformere
- 0
Maschinenlesbare Strukturkennungen
- SMILES
CCCCCCCCCCCCCCCC(=O)OC/C=C(\C)/C=C/C=C(\C)/C=C/C1=C(CCCC1(C)C)C- InChI
InChI=1S/C36H60O2/c1-7-8-9-10-11-12-13-14-15-16-17-18-19-25-35(37)38-30-28-32(3)23-20-22-31(2)26-27-34-33(4)24-21-29-36(34,5)6/h20,22-23,26-28H,7-19,21,24-25,29-30H2,1-6H3/b23-20+,27-26+,31-22+,32-28+- InChIKey
VYGQUTWHTHXGQB-FFHKNEKCSA-N
Am 2026-08-31 von NIH PubChem durch prüfsummengültigen CAS-Abgleich abgerufen. Chemische Eigenschaften ersetzen nicht die regulatorische Entscheidung auf dieser Seite.
Amtliche Quelle und Herkunft
- Registrierte Quelle
- Saudi SFDA prohibited and restricted ingredient lists
- Quellenverweis
- SFDA restricted list, page 36, row 9
- Eintrags-ID der Quelle
restricted-35-9- Quellenversion
- live-snapshot-2026-08-30
- Quellsprache
- English
- Übersetzungsstatus
- Original is English
- Stand geprüft
- 2026-08-30 05:18 UTC
- Validierungsmethode
- complete SFDA paginated HTML snapshot; strict page/row counts
- SHA-256
ceb6cc636e6b1f4b3013f88ce0297217b49d6194342c6ece5c03b1e04256d71a
Hinweise zum registrierten Datensatz
- Datensatzabdeckung
- Prohibited and restricted substances with CAS, EC and conditions
- Hinweis zur Behörde
- Official SFDA dated lists; version and hash each release
Wie dieser Eintrag in den Marktdatensatz passt
Statusverteilung
Bedingungstext ist bei 0 von 2090 aktuellen Einträgen vorhanden. Ein leeres Bedingungsfeld wird entsprechend der oben genannten Eintragsart interpretiert; es wird niemals in die Aussage einer uneingeschränkten Verwendung umgedeutet.
Saudi Arabia Marktkontext
Complete official list index
Abdeckungsversion: SFDA live prohibited/restricted lists, snapshot 30 August 2026
Every page and entry in the public SFDA prohibited and restricted ingredient indexes; restricted detail pages remain the source for conditions.
Verifizierungs-Checkliste
- Search names and CAS across both SFDA lists.
- Open the cited restricted-entry detail and apply every condition.
- Check current SFDA/GSO technical regulations and updates.
- Complete eCosma notification, label and responsible-party requirements.
Amtliche Marktquellen
- Saudi SFDA prohibited and restricted ingredient listsOfficial SFDA dated lists; version and hash each release
Verifizierungsablauf und Vollständigkeit des Eintrags
Bevor Sie dieses Ergebnis für eine Compliance-Entscheidung verwenden
- Bestätigen Sie, dass „(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraen-1-ol; [(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenyl] acetate; [(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenyl] hexadecanoate“ und jede CAS-/EC-Kennung sich auf das Material in Ihrer Lieferantenspezifikation beziehen.
- Search names and CAS across both SFDA lists.
- Open the cited restricted-entry detail and apply every condition.
- Check current SFDA/GSO technical regulations and updates.
- Complete eCosma notification, label and responsible-party requirements.
- Dokumentieren Sie die Quellenversion und prüfen Sie die Behörde vor Herstellung, Notifizierung oder Inverkehrbringen erneut.
In diesem Eintrag verfügbare Felder
- Amtlicher StoffnameVerfügbar
- CASVerfügbar
- ECVerfügbar
- Gesonderter BedingungstextIn der Quellzeile nicht vorhanden
- Datum des InkrafttretensNicht angegeben
- Snapshot-Hash und MethodeVerfügbar
Fragen, die diese Seite beantwortet
Dauerhafte Zitierweise
(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraen-1-ol; [(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenyl] acetate; [(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenyl] hexadecanoate. SFDA restricted list, page 36, row 9. Saudi Arabia. Source version live-snapshot-2026-08-30. CosIng Checker regulatory record: https://cosingchecker.com/de/regulations/sa/records/11684/
Zitieren Sie die Aufsichtsbehörde als rechtliche Autorität. Diese Seite ist ein strukturierter Belegindex und eine Verifizierungshilfe, kein Ersatz für den amtlichen Text oder eine fachkundige rechtliche Bewertung.
Auslegung und Grenzen für Saudi Arabia
This substance is not unrestricted: cosmetic use is subject to the conditions in the cited official record.
Check product type, body area, concentration, purity and warning requirements before deciding whether a formulation is compliant.
Wie die Rechtsrolle auszulegen ist
The cited row forms part of a binding rule or legally incorporated list for this market.
Belege auf dieser Seite
- Erfasstes Ergebnis: Restricted
- Rechtsrolle: Binding rule
- Quellenversion: live-snapshot-2026-08-30
Was es nicht beweist
No list match is not permission; Gulf/SFDA product, claim, notification and technical requirements still apply.
Weitere maßgebliche Stoffrecherche
Keine dieser Quellen hebt die oben genannte Marktentscheidung auf.
Cosmetic Ingredient Review safety assessments
Expert Panel conclusions, assessed ingredient groups, use conditions, dates and report documents
Independent expert review considered by FDA; not a government approval or binding market rule
Diese Identität bei der Quelle recherchierenFDA Global Substance Registration System
UNII identifiers, preferred names, substance types, codes and public substance relationships
Identity registry only; UNII availability does not imply FDA review or approval
Diese Identität bei der Quelle recherchierenILO/WHO International Chemical Safety Cards
Hazards, symptoms, first aid, storage, incompatibilities and physical properties for covered chemicals
International occupational chemical-safety reference; not cosmetic-use approval
Diese Identität bei der Quelle recherchierenJapan NITE-CHRIP
Chemical identity, Japanese and foreign legal lists, GHS hazards and exposure-related information
Chemical-management evidence; cosmetic status remains governed by the applicable MHLW standard and market rules
Diese Identität bei der Quelle recherchierenNIOSH Pocket Guide to Chemical Hazards
REL, PEL, IDLH, properties, exposure routes, symptoms, target organs, first aid and measurement methods for covered workplace chemicals
US occupational-health guidance and limits; not a cosmetic ingredient decision
Diese Identität bei der Quelle recherchierenOECD eChemPortal
Gateway to authority-owned physical-property, fate, ecotoxicity, toxicity, exposure and GHS records
Discovery gateway; each linked authority remains responsible for its data
Diese Identität bei der Quelle recherchierenUS EPA CompTox CTX APIs
Für den Import ist ein API-Schlüssel erforderlichDTXSID identity, experimental and predicted properties, toxicity, bioactivity, exposure and environmental data
Scientific and computational evidence; predictions must remain labelled and do not determine cosmetic legality
Diese Identität bei der Quelle recherchieren